166 related articles for article (PubMed ID: 12847731)
1. Immunotherapy for hayfever.
Durham SR; Walker S
Chem Immunol; 2000; 78():199-208. PubMed ID: 12847731
[No Abstract] [Full Text] [Related]
2. Allergic rhinitis. Outcomes of immunotherapy on symptom control.
Cook PR
Otolaryngol Clin North Am; 1998 Feb; 31(1):129-40. PubMed ID: 9530682
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
Wise SK; Schlosser RJ
Otolaryngol Clin North Am; 2012 Oct; 45(5):1045-54. PubMed ID: 22980684
[TBL] [Abstract][Full Text] [Related]
4. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
Wolthers OD; Høst A; Frederiksen B; Halken S
Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
[TBL] [Abstract][Full Text] [Related]
5. Treating allergic rhinitis by sublingual immunotherapy: a review.
Incorvaia C; Di Rienzo A; Celani C; Makrì E; Frati F
Ann Ist Super Sanita; 2012; 48(2):172-6. PubMed ID: 22751560
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
Cochard MM; Eigenmann PA
J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
[No Abstract] [Full Text] [Related]
7. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study.
Cirla AM; Cirla PE; Parmiani S; Pecora S
Allergol Immunopathol (Madr); 2003; 31(1):31-43. PubMed ID: 12573207
[TBL] [Abstract][Full Text] [Related]
8. Monoid sublingual immunotherapy.
Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
Hordijk GJ; Antvelink JB; Luwema RA
Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
[TBL] [Abstract][Full Text] [Related]
10. Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials.
Calderon MA; Eichel A; Makatsori M; Pfaar O
Curr Opin Allergy Clin Immunol; 2012 Jun; 12(3):249-56. PubMed ID: 22499145
[TBL] [Abstract][Full Text] [Related]
11. Meta-analyses of specific immunotherapy trials.
Calderon MA
Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
[No Abstract] [Full Text] [Related]
12. [Allergen specific immunotherapy: new approaches].
Tay F; Kündig TM; Senti G
Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
[TBL] [Abstract][Full Text] [Related]
14. Future developments in sublingual immunotherapy.
Didier A
Allergy; 2006; 61 Suppl 81():29-31. PubMed ID: 16792604
[TBL] [Abstract][Full Text] [Related]
15. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
Fuchs T; Klimek L
HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
[No Abstract] [Full Text] [Related]
16. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
[TBL] [Abstract][Full Text] [Related]
17. Do indications to sublingual immunotherapy need to be revised?
Incorvaia C; Mauro M
J Allergy Clin Immunol; 2010 Jan; 125(1):277; author reply 277-8. PubMed ID: 20109757
[No Abstract] [Full Text] [Related]
18. Subcutaneous versus sublingual immunotherapy.
Lin CH; Alandijani S; Lockey RF
Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
[No Abstract] [Full Text] [Related]
19. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
20. [Vaccination with allergens in children].
Demoly P; Dhivert-Donnadieu H; Bousquet J
Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
